Literature DB >> 8606618

Agmatine treatment is neuroprotective in rodent brain injury models.

G M Gilad1, K Salame, J M Rabey, V H Gilad.   

Abstract

Agmatine is a naturally occurring guanidino compound, found in bacteria and plants, with several proposed nervous system-related functions suggestive of beneficial effects in central nervous system injury. Here evidence is presented that agmatine can exert potent neuroprotection in both in vitro and in vivo rodent models of neurotoxic and ischemic brain injuries. The cumulative evidence lead us to suggest that agmatine, a relatively nontoxic compound, be tried for potential therapeutic use after neurotrauma and in neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606618     DOI: 10.1016/0024-3205(95)02274-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  38 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Agmatine induces gastric protection against ischemic injury by reducing vascular permeability in rats.

Authors:  Abeer A Al Masri; Eman El Eter
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

3.  Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.

Authors:  G Olmos; N DeGregorio-Rocasolano; M Paz Regalado; T Gasull; M Assumpció Boronat; R Trullas; A Villarroel; J Lerma; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 4.  Oxidation of polyamines and brain injury.

Authors:  N Seiler
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

5.  Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.

Authors:  Gad M Gilad; Varda H Gilad; John P M Finberg; Jose M Rabey
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

6.  Chronic treatment with glucocorticoids alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels.

Authors:  Meng-Yang Zhu; Wei-Ping Wang; Jingjing Huang; Soundar Regunathan
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

7.  Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure.

Authors:  B Lewis; K A Wellmann; S Barron
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

8.  Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia.

Authors:  Che-Chuan Wang; Chung-Ching Chio; Ching-Hong Chang; Jinn-Rung Kuo; Ching-Ping Chang
Journal:  BMC Pharmacol       Date:  2010-09-06

9.  Agmatine reduces ultrasonic vocalization deficits in female rat pups exposed neonatally to ethanol.

Authors:  Kristen Wellmann; Ben Lewis; Susan Barron
Journal:  Neurotoxicol Teratol       Date:  2009-11-27       Impact factor: 3.763

10.  Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage.

Authors:  John E Piletz; Stephanie Klenotich; Ken S Lee; Qian Long Zhu; Edward Valente; Michael A Collins; Vyvyca Jones; Soeb Nam Lee; Feng Yangzheng
Journal:  Neurotox Res       Date:  2013-01-19       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.